Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments

Go back to Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments
(NASDAQ: MNPR) Delayed: 116.28 -1.29 (1.1%)
Previous Close $117.57    52 Week High
Open $119.04    52 Week Low
Day High $121.00    P/E N/A 
Day Low $114.28    EPS
Volume 203,353